News

Efficacy of action of the bioactive AMYCOT successfully tested against target organisms in laboratory conditions and confirmed by an independent testing laboratory in 2003.

Products utilising the bioactive AMYCOTdeveloped and tested for efficacy and safety in laboratory conditions and in clinics in 2004/06.

Commercialisation commenced with shipments to a licensee in Germany in August 2005.

The Calmagen range of products was launched on the Australian market in November 2006.

Shipments commenced to South Africa in July 2008.